ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 360 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,983 | -31.4% | 70,607 | -33.7% | 0.01% | -53.6% |
| Q3 2023 | $2,892 | -80.6% | 106,544 | -78.0% | 0.03% | -76.9% |
| Q2 2023 | $14,915 | +109.2% | 485,198 | +145.2% | 0.12% | +105.1% |
| Q1 2023 | $7,131 | +13.5% | 197,915 | +24.5% | 0.06% | -35.2% |
| Q4 2022 | $6,282 | -97.8% | 158,964 | +2155.8% | 0.09% | +2175.0% |
| Q3 2022 | $283,000 | -92.2% | 7,047 | -92.5% | 0.00% | -91.3% |
| Q1 2022 | $3,642,000 | -16.0% | 93,492 | -11.6% | 0.05% | -4.2% |
| Q2 2021 | $4,334,000 | +498.6% | 105,724 | +537.0% | 0.05% | +336.4% |
| Q1 2021 | $724,000 | -92.7% | 16,596 | -92.9% | 0.01% | -94.4% |
| Q3 2020 | $9,852,000 | +795.6% | 234,190 | +933.8% | 0.20% | +575.9% |
| Q2 2020 | $1,100,000 | – | 22,654 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |